Abstract
Large pharmaceutical firms, biotechnology firms, publicly funded research organisations and financial organisations which are inseparably connected and located in a few key regions have built a hierarchical pharma-biotech complex. It is argued that large corporations establish networks to access regionally concentrated knowledge bases. These networks consist of money flows, knowledge and personnel. By establishing such networks, large firms considerably shape and interconnect the development dynamics in the regions in which they have strategic assets. The paper reveals how the economic development trajectories of the urban regions of Basel, New Jersey and Boston are connected by large pharmaceutical firms and the industrial dynamics of the combined pharmaceutical and biotechnology industries. Such strong corporate networks result in the globally combined and interdependent development of urban regions.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
